SKI Market

Indian Indices

Nifty

24,683.90 -261.55
(-1.05%)

Sensex

81,596.63 410.19
( 0.51%)

Bank Nifty

54,877.35 -543.35
( -0.98%)

Nifty IT

37,283.50 -194.30
( -0.52%)

Global Indices

Nasdaq

42,705.04 -108.03
(-0.25%)

Dow Jones

5,962.37 -22.23
(-0.37%)

Hang Seng

37,467.16 -31.47
(-0.08%)

Nikkei 225

8,781.12 81.81
(0.94%)

Forex

USD-INR

85.43 -0.14
(-0.16%)

EUR-INR

95.92 0.38
(0.40%)

GBP-INR

114.01 0.38
(0.34%)

JPY-INR

0.59 0.00
(0.25%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

411.1031908

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

61.38

1221.26

EPS(TTM)

Face Value()

Div & Yield %

33.77

Back

pfc ltd

Remus Pharmaceuticals Ltd - Certificate under SEBI (Depositories and Participants) Regulations, 2018

Apr 16,2025

Remus Pharmaceuticals Limited has informed the Exchange about submission of Reconciliation of Share Capital Audit Report for the quarter ended March 31, 2025 under SEBI (Depositories and Participants) Regulations, 2018.

24,683.90 -261.55 (-1.05%)

81,596.63 410.19 ( 0.51%)

54,877.35 -543.35 ( -0.98%)

37,283.50 -194.30 ( -0.52%)

42,705.04 -108.03 (-0.25%)

5,962.37 -22.23 (-0.37%)

37,467.16 -31.47 (-0.08%)

8,781.12 81.81 (0.94%)

85.43 -0.14 (-0.16%)

95.92 0.38 (0.40%)

114.01 0.38 (0.34%)

0.59 0.00 (0.25%)